BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 26387629)

  • 1. Prevalence of BTK mutations in male Algerian patterns with agammaglobulinemia and severe B cell lymphopenia.
    Boushaki S; Tahiat A; Meddour Y; Chan KW; Chaib S; Benhalla N; Smati L; Bensenouci A; Lau YL; Magdinier F; Djidjik R
    Clin Immunol; 2015 Dec; 161(2):286-90. PubMed ID: 26387629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. X-Linked Agammagobulinemia in a Large Series of North African Patients: Frequency, Clinical Features and Novel BTK Mutations.
    Aadam Z; Kechout N; Barakat A; Chan KW; Ben-Ali M; Ben-Mustapha I; Zidi F; Ailal F; Attal N; Doudou F; Abbadi MC; Kaddache C; Smati L; Touri N; Chemli J; Gargah T; Brini I; Bakhchane A; Charoute H; Jeddane L; El Atiqi S; El Hafidi N; Hida M; Saile R; Alj HS; Boukari R; Bejaoui M; Najib J; Barbouche MR; Lau YL; Mellouli F; Bousfiha AA
    J Clin Immunol; 2016 Apr; 36(3):187-94. PubMed ID: 26931785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. X-linked agammaglobulinemia in a 10-year-old boy with a novel non-invariant splice-site mutation in Btk gene.
    Maekawa K; Yamada M; Okura Y; Sato Y; Yamada Y; Kawamura N; Ariga T
    Blood Cells Mol Dis; 2010 Apr; 44(4):300-4. PubMed ID: 20122858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical characteristics and prenatal diagnosis for 22 families in Henan Province of China with X-linked agammaglobulinemia (XLA) related to Bruton's tyrosine kinase (BTK) gene mutations.
    Gao S; Hu S; Duan H; Wang L; Kong X
    BMC Med Genet; 2020 Jun; 21(1):131. PubMed ID: 32552675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mutation analysis and prenatal diagnosis in families of X-linked agammaglobulinemia caused by BTK gene mutation].
    Kong X; Mo G; Liu N; Tian P; Chen M
    Zhonghua Yi Xue Za Zhi; 2014 May; 94(18):1405-8. PubMed ID: 25142992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of Bruton's tyrosine kinase mutations in Mexican patients with X-linked agammaglobulinemia.
    Lopez-Herrera G; Berron-Ruiz L; Mogica-Martinez D; Espinosa-Rosales F; Santos-Argumedo L
    Mol Immunol; 2008 Feb; 45(4):1094-8. PubMed ID: 17765309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BTK: 22 novel and 25 recurrent mutations in European patients with X-linked agammaglobulinemia.
    Fiorini M; Franceschini R; Soresina A; Schumacher RF; Ugazio AG; Rossi P; Plebani A; Notarangelo LD
    Hum Mutat; 2004 Mar; 23(3):286. PubMed ID: 14974089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. De novo mutation in the BTK gene of atypical X-linked agammaglobulinemia in a patient with recurrent pyoderma.
    Lin MT; Chien YH; Shyur SD; Huang LH; Chiang YC; Wen DC; Liang PH; Yang HC
    Ann Allergy Asthma Immunol; 2006 May; 96(5):744-8. PubMed ID: 16729790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel Bruton's tyrosine kinase gene (BTK) invariant splice site mutation in a Malaysian family with X-linked agammaglobulinemia.
    Chear CT; Gill HK; Ramly NH; Dhaliwal JS; Bujang N; Ripen AM; Mohamad SB
    Asian Pac J Allergy Immunol; 2013 Dec; 31(4):320-4. PubMed ID: 24383975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BTK mutations in patients with X-linked agammaglobulinemia: lack of correlation between presence of peripheral B lymphocytes and specific mutations.
    Tao L; Boyd M; Gonye G; Malone B; Schwaber J
    Hum Mutat; 2000 Dec; 16(6):528-9. PubMed ID: 11102984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delayed diagnosis in X-linked agammaglobulinemia and its relationship to the occurrence of mutations in BTK non-kinase domains.
    Carrillo-Tapia E; García-García E; Herrera-González NE; Yamazaki-Nakashimada MA; Staines-Boone AT; Segura-Mendez NH; Scheffler-Mendoza SC; O Farrill-Romanillos P; Gonzalez-Serrano ME; Rodriguez-Alba JC; Santos-Argumedo L; Berron-Ruiz L; Sanchez-Flores A; López-Herrera G
    Expert Rev Clin Immunol; 2018 Jan; 14(1):83-93. PubMed ID: 29202590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct Clinical Features and Novel Mutations in Taiwanese Patients With X-Linked Agammaglobulinemia.
    Yeh YH; Hsieh MY; Lee WI; Huang JL; Chen LC; Yeh KW; Ou LS; Yao TC; Wu CY; Lin SJ
    Front Immunol; 2020; 11():2001. PubMed ID: 33013854
    [No Abstract]   [Full Text] [Related]  

  • 13. Identification of the bruton tyrosine kinase (BTK) gene mutations in 20 Australian families with X-linked agammaglobulinemia (XLA).
    Velickovic M; Prasad ML; Weston SA; Benson EM
    Hum Mutat; 2004 Apr; 23(4):398-9. PubMed ID: 15024743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel BTK gene mutation creates a de-novo splice site in an X-linked agammaglobulinemia patient.
    Chear CT; Ripen AM; Mohamed SA; Dhaliwal JS
    Gene; 2015 Apr; 560(2):245-8. PubMed ID: 25680287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of novel Bruton's tyrosine kinase gene mutations in Central European patients with agammaglobulinemia.
    Kristufek D; Aspalter RM; Eibl MM; Wolf HM
    Mol Immunol; 2007 Mar; 44(7):1639-43. PubMed ID: 17045652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bruton tyrosine kinase gene mutations in Turkish patients with presumed X-linked agammaglobulinemia.
    Wang Y; Kanegane H; Sanal O; Ersoy F; Tezcan I; Futatani T; Tsukada S; Miyawaki T
    Hum Mutat; 2001 Oct; 18(4):356. PubMed ID: 11668622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical, immunological and molecular characteristics of 37 Iranian patients with X-linked agammaglobulinemia.
    Aghamohammadi A; Fiorini M; Moin M; Parvaneh N; Teimourian S; Yeganeh M; Goffi F; Kanegane H; Amirzargar AA; Pourpak Z; Rezaei N; Salavati A; Pouladi N; Abdollahzade S; Notarangelo LD; Miyawaki T; Plebani A
    Int Arch Allergy Immunol; 2006; 141(4):408-14. PubMed ID: 16943681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation screening of the BTK gene in 56 families with X-linked agammaglobulinemia (XLA): 47 unique mutations without correlation to clinical course.
    Holinski-Feder E; Weiss M; Brandau O; Jedele KB; Nore B; Bäckesjö CM; Vihinen M; Hubbard SR; Belohradsky BH; Smith CI; Meindl A
    Pediatrics; 1998 Feb; 101(2):276-84. PubMed ID: 9445504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular and structural characterization of five novel mutations in the Bruton's tyrosine kinase gene from patients with X-linked agammaglobulinemia.
    Saha BK; Curtis SK; Vogler LB; Vihinen M
    Mol Med; 1997 Jul; 3(7):477-85. PubMed ID: 9260159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. X-chromosome inactivation and mutation pattern in the Bruton's tyrosine kinase gene in patients with X-linked agammaglobulinemia. Italian XLA Collaborative Group.
    Moschese V; Orlandi P; Plebani A; Arvanitidis K; Fiorini M; Speletas M; Mella P; Ritis K; Sideras P; Finocchi A; Livadiotti S; Rossi P
    Mol Med; 2000 Feb; 6(2):104-13. PubMed ID: 10859027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.